Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.

Phase 4CompletedNCT02049255

Astes50 enrolled

Overview

Comparison the use of marcaine and chloroprocaine in rachianesthesia for a surgical correction of inguinal hernia. Comparision between acute and chronic (3 months and 6 months) pain.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Pain

Interventions

ChloroprocaineDRUG

The Group "Chloroprocaine" will receive: Chloroprocaine: 50 mg in rachianesthesia

MarcaineDRUG

The Group "Marcaine" will receive: Marcaine: 12,5 mg in rachianesthesia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults under rachianesthesia Exclusion Criteria: * Personal history of gastric ulcus * ASA 4 * Emergency * Combined surgery

Locations (1)

Clinique Saint-Luc Bouge

Bouge, Namur, Belgium

Outcomes

Primary Outcomes

Acute pain

Time frame: 1 day of the surgery when patient leave the recovery room

Secondary Outcomes

Chronic pain

Time frame: at 3 and 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.